Stroke: open trials in Canada

• NCT07906275

  INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  Trial Treatment · Phase 3 · University of Calgary

  University of Calgary- Foothills Medical Centre, Calgary · University of Alberta, Edmonton · University of British Columbia, Vancouver · University of Manitoba - Winnipeg Health Science Centre, Winnipeg

  Registry updated 2026-10-30

• NCT07896889

  Cardiac CT Angiography in Acute Stroke Imaging (SCOPE-CT)

  Trial Treatment · Ottawa Hospital Research Institute

  The Ottawa Hospital, Ottawa

  Registry updated 2026-10-27

• NCT07626411

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Diex Recherche Inc., Sherbrooke

  Registry updated 2026-10-26

• NCT07454707

  Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

  Trial Treatment · Phase 3 · Sunnybrook Health Sciences Centre

  Sunnybrook Health Sciences Centre, Toronto

  Registry updated 2026-10-23

• NCT07702643

  Behavioral Intervention and Guided Stepping Training Early Post-Stroke

  Trial Treatment · University of Alberta

  Carewest Dr Vernon Fanning Centre, Calgary · Foothills Medical Center, Calgary · Glenrose Rehabilitation Hospital, Edmonton · Grey Nuns Community Hospital, Edmonton · Royal Alexandra Hospital, Edmonton · University of Alberta Hospital, Edmonton

  Registry updated 2026-10-23

• NCT06320431

  ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  Trial Treatment · Phase 3 · University of Calgary

  Brandon Regional Hospital, Brandon · University Of Calgary, Calgary · Queen Elizabeth Hospital (PEI), Charlottetown · University of Alberta, Edmonton · Health Sciences North Horizon Sante-Nord, Greater Sudbury · Queen Elizabeth II Health Science Center (Halifax), Halifax · McMaster University Hamilton Health Sciences Centre, Hamilton · Kelowna Regional Hospital, Kelowna · Kingston General Hospital, Kingston · Lawson Health Research Institute- London, London · Medicine Hat Regional Hospital, Medicine Hat · Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal · Royal Columbian Hospital, New Westminster · Ottawa Hospital Research Institute, Ottawa · Red Deer Regional Hospital, Red Deer · Royal University Hospital, Saskatoon · CIUSSS de l'Estrie - CHUS Fleurimont Hôpital (Sherbrooke), Sherbrooke · Sunnybrook Health Science Centre, Toronto · St. Michael's Hospital, Toronto · University of British Columbia, Vancouver · University of Manitoba - Winnipeg Health Science Centre, Winnipeg

  Registry updated 2026-10-21

• NCT07175428

  Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  Trial Treatment · Phase 2 · Regeneron Pharmaceuticals

  University of Alberta Hospital - Cardiology, Edmonton · Health sciences North - Cardiology, Greater Sudbury · Hamilton Health Sciences Corporation, Hamilton · Hamilton Medical Research Group (HMRG), Hamilton · Viacar Recherches Cliniques Inc. - Cardiologie, Longueuil · GA Research Associates Ltd., Moncton · Montreal Heart Institute, Montreal · Dr James Cha, Oshawa · CHU de Quebec-Universite Laval, Québec · CISSS du Bas-Saint-Laurent - Hopital regional de Rimouski - Cardiologie, Rimouski · Heart Health Institute Research Inc. - Cardiology, Scarborough Village · Diex Recherche Inc., Sherbrooke · Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Cardiologie, Sherbrooke · CISSSLAN, Hopital Pierre-Le Gardeur, Terrebonne · Diex Recherche Trois-Rivieres, Trois-Rivières · Victoria Cardiac Arrhythmia Trials, Victoria

  Registry updated 2026-10-21

• NCT07687056

  ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  Trial Treatment · Phase 3 · University of Calgary

  University of Calgary- Foothills Medical Centre, Calgary · University of Alberta, Edmonton · Health Sciences North Horizon Sante-Nord, Greater Sudbury · Kelowna Regional Hospital, Kelowna · CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal · Royal Columbian Hospital, New Westminster · Ottawa Civic Hospital, Ottawa · Royal University Hospital, Saskatoon · CIUSSS de l'Estrie - CHUS Fleurimont Hôpital (Sherbrooke), Sherbrooke · Sunnybrook Health Science Centre, Toronto · University of British Columbia, Vancouver · University of Manitoba - Winnipeg Health Science Centre, Winnipeg

  Registry updated 2026-10-21

• NCT07107022

  Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).

  Research · Penumbra Inc.

  Kelowna General Hospital, Kelowna · Toronto Western Hospital, Toronto

  Registry updated 2026-10-20

• NCT05733416

  Intensive Cancer Screening After Cryptogenic Stroke

  Trial Treatment · Ottawa Hospital Research Institute

  Calgary Foothills Medical Centre, Calgary · Centre Hospitalier de l'Université de Montréal, Montreal · The Ottawa Hospital, Ottawa

  Registry updated 2026-10-15

• NCT07430956

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Hamilton Medical Research Group (HMRG), Hamilton

  Registry updated 2026-10-14

• NCT06226805

  Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

  Trial Treatment · Phase 2 · Basking Biosciences, Inc.

  University Of Calgary, Calgary · University of Alberta Hospital, Edmonton · Ottawa Hospital Research Institute, Ottawa · Vancouver Stroke Program, Vancouver

  Registry updated 2026-10-13

• NCT07576647

  Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)

  Trial Treatment · McMaster University

  Foothills Medical Centre, Calgary · Sunnybrook Health Sciences Centre, Toronto · Vancouver General Hospital, Vancouver

  Registry updated 2026-10-09

• NCT07717710

  Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults

  Trial Treatment · Early phase 1 · University of British Columbia

  SportsCardiologyBC, UBC Hospital, Vancouver

  Registry updated 2026-10-09

• NCT07241390

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Centricity Research Brampton Endocrinology, Brampton · Cambridge Cardiac Care Centre, Cambridge · Ecogene-21, Chicoutimi · Premier Clinical Trial Network, Hamilton · The Wharton Medical Clinic Clinical Trials Inc, Hamilton · THEO Medical Concorde, Laval · G A Research Associates, Moncton · Applied Medical Informatics Research, Montreal · Diex Recherche Inc. Division Quebec, Québec · CHU de Quebec-Universite Laval-Hotel Dieu de Quebec, Québec · Bluewater Clinical Research Group Inc., Sarnia · Heart Health Institute - Scarborough Office, Scarborough · Kidney Care Centre - Surrey, Surrey · Diex Recherche Inc. Division Trois-Rivieres, Trois-Rivières · C.I.C. Mauricie inc., Trois-Rivières · Clinical Research Solutions - Kitchener, Waterloo · Winchester District Memorial Hospital, Winchester · Glanz Medicine Professional Corporation, Windsor · Seven Oaks General Hospital, Winnipeg

  Registry updated 2026-10-08

• NCT04559373

  Virtual Reality and Field Training to Enhance Community Walking After Stroke

  Trial Treatment · McGill University

  Jewish Rehabilitation Hospital, Laval · Institut de réadaptation en déficience physique de Québec, Québec

  Registry updated 2026-10-07

• NCT06621771

  Playing Piano to Improve Hand Function Early After Stroke

  Trial Treatment · McGill University

  Jewish Rehabilitation Hospital, Laval

  Registry updated 2026-10-07

• NCT07178535

  Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke

  Trial Treatment · McGill University

  Jewish Rehabilitation Hospital - CISSS Laval, Laval

  Registry updated 2026-10-07

• NCT06495450

  Using Omnidirectional Virtual Reality and Treadmill Training for Chronic Stroke

  Trial Treatment · Nova Scotia Health Authority

  Nova Scotia Rehabilitation & Arthritis Centre, Halifax

  Registry updated 2026-10-06

• NCT04774159

  Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  Trial Treatment · Phase 3 · Population Health Research Institute

  University of Calgary, Peter Lougheed Centre Vascular Clinic, Calgary · University of Alberta Mazankowski Heart Institute, Edmonton · Hamilton General Hospital, Hamilton · London Health Sciences Centre, London · Centre Hospitalier de l'Université de Montréal, Montreal · CIUSSS du Nord-de-l'île-de-Montréal, Hôpital du Sacré-Cœur-de-Montréal, Montreal · Vascular Health Bronte, Oakville · Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent, Rimouski · Corcare Cardiovascular Research Inc., Scarborough Village · Niagara Health System, St. Catharines · Sunnybrook Research Institute, Toronto

  Registry updated 2026-10-05

• NCT04642430

  COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

  Trial Treatment · Phase 4 · Ottawa Hospital Research Institute

  CISSS de l'Outaouais, Gatineau · QEII Health Science Centre, Halifax · Kingston General Hospital, Kingston · CHU de Québec-Université Laval, Laval · Ciusss Nim, Montreal · The Ottawa Hospital - General Campus, Ottawa · University Ottawa Heart Institute, Ottawa · Victoria Cardiac Arrhythmia Trials, Victoria

  Registry updated 2026-10-01

• NCT06555016

  Optimal Intensity of Reactive Balance Training Post-stroke

  Trial Treatment · Toronto Rehabilitation Institute

  Toronto Rehabilitation Institute, Toronto

  Registry updated 2026-10-01

• NCT06571149

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  Trial Treatment · Phase 4 · Insel Gruppe AG, University Hospital Bern

  Hamilton Health Sciences, Hamilton

  Registry updated 2026-09-30

• NCT06990867

  Optimizing Reperfusion to Improve Outcomes and Neurologic Function

  Trial Treatment · Phase 2/3 · Corxel Pharmaceuticals

  Corxel Investigational Site, Edmonton · Corxel Investigational Site, Kingston · Corxel Investigational Site, Winnipeg

  Registry updated 2026-09-21

• NCT05714618

  MR Evidence of Cardiac Inflammation Post-Stroke

  Research · Luciano A. Sposato

  Heart & Brain Lab, Western University, London

  Registry updated 2026-09-18

All Stroke trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error